239 related articles for article (PubMed ID: 9566979)
1. Mannose 6-phosphate/insulin-like growth factor-II receptor targets the urokinase receptor to lysosomes via a novel binding interaction.
Nykjaer A; Christensen EI; Vorum H; Hager H; Petersen CM; Røigaard H; Min HY; Vilhardt F; Møller LB; Kornfeld S; Gliemann J
J Cell Biol; 1998 May; 141(3):815-28. PubMed ID: 9566979
[TBL] [Abstract][Full Text] [Related]
2. Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor.
Olson LJ; Yammani RD; Dahms NM; Kim JJ
EMBO J; 2004 May; 23(10):2019-28. PubMed ID: 15085180
[TBL] [Abstract][Full Text] [Related]
3. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of mannose 6-phosphate receptors and their ligands during the myogenic development of C2 cells.
Szebenyi G; Rotwein P
J Biol Chem; 1991 Mar; 266(9):5534-9. PubMed ID: 1848553
[TBL] [Abstract][Full Text] [Related]
5. Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation.
Wood RJ; Hulett MD
J Biol Chem; 2008 Feb; 283(7):4165-76. PubMed ID: 18073203
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
Ploug M
Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
[TBL] [Abstract][Full Text] [Related]
7. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.
Leksa V; Schiller HB; Stockinger H
Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541
[TBL] [Abstract][Full Text] [Related]
8. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
9. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
10. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells.
Busso N; Masur SK; Lazega D; Waxman S; Ossowski L
J Cell Biol; 1994 Jul; 126(1):259-70. PubMed ID: 7517943
[TBL] [Abstract][Full Text] [Related]
11. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
12. Biosynthetic labeling of beta-hexosaminidase B: inhibition of the cellular uptake of lysosomal secretions containing [3H]hexosaminidase B by insulin-like growth factor-II in rat C6 glial cells.
Kessler U; Aumeier S; Funk B; Kiess W
Mol Cell Endocrinol; 1992 Dec; 90(1):147-53. PubMed ID: 1301395
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
[TBL] [Abstract][Full Text] [Related]
14. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.
Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H
Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
16. Soluble mannose 6-phosphate/insulin-like growth factor II (IGF-II) receptor inhibits interleukin-6-type cytokine-dependent proliferation by neutralization of IGF-II.
Duplomb L; Chaigne-Delalande B; Vusio P; Raher S; Jacques Y; Godard A; Blanchard F
Endocrinology; 2003 Dec; 144(12):5381-9. PubMed ID: 12959977
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate.
Miller JJ; Bohnsack RN; Olson LJ; Ishihara M; Aoki K; Tiemeyer M; Dahms NM
Sci Rep; 2021 Apr; 11(1):8213. PubMed ID: 33859256
[TBL] [Abstract][Full Text] [Related]
18. The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface.
Behrendt N; Rønne E; Danø K
Biol Chem Hoppe Seyler; 1995 May; 376(5):269-79. PubMed ID: 7662169
[TBL] [Abstract][Full Text] [Related]
19. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.
Hartman MA; Kreiling JL; Byrd JC; MacDonald RG
FEBS J; 2009 Apr; 276(7):1915-29. PubMed ID: 19236480
[TBL] [Abstract][Full Text] [Related]
20. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
